{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T20:48:29Z","timestamp":1740170909239,"version":"3.37.3"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"11-12","license":[{"start":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T00:00:00Z","timestamp":1624665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,29]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Medication-assisted treatment has been shown to be effective in treating opioid use disorder among both older adults and veterans of U.S. Armed Forces. However, limited evidence exists on MAT\u2019s differential effect on treatment completion across age groups. This study aims to ascertain the role of MAT and age in treatment completion among veterans seeking treatment in non\u2013Department of Veterans Affairs healthcare facilities for opioid use disorder.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We used the Treatment Episode Data Set\u2014Discharges (TEDS-D; 2006-2017) to examine trends in treatment and MAT usage over time and TEDS-2017 to determine the role of age and MAT in treatment completion. We examined a subset of those who self-identified as veterans and who sought treatment for an opioid use disorder.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Veterans presented in treatment more often as heroin users than prescription opioid users, and older veterans were more likely to get MAT than younger veterans. We found that before propensity score matching, MAT initially appeared to be associated with a lower likelihood of treatment completion in inpatient ($\\beta $ = \u22121.47, 95% CI \u22121.56 to \u22121.39) and outpatient ($\\beta $ = \u22121.40, 95% CI \u22122.21 to \u22120.58) settings, and age (50+ years) appeared to mediate the effect of MAT on treatment completion ($\\beta $ = \u22120.54, 95% CI \u22120.87 to \u22120.21). After matching, older veterans were more likely to complete substance use disorder treatment ($\\beta $ = 0.21, 95% CI 0.01-0.42), while age no longer mediated the effect of MAT, and MAT had a significant positive impact on treatment completion in detox settings ($\\beta $ = 1.36, 95% CI 1.15-1.50) and inpatient settings ($\\beta $ = 1.54, 95% CI 1.37 -1.71).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The results show that age plays an important role in outpatient treatment completion, while MAT plays an important role in inpatient treatment completion. Implications for veterans are discussed.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/milmed\/usab242","type":"journal-article","created":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T15:43:22Z","timestamp":1624722202000},"page":"1432-1440","source":"Crossref","is-referenced-by-count":0,"title":["Association of Medication-Assisted Treatment and Age With Treatment Completion Among Veterans Seeking Non-VA Treatment for Opioid use Disorder at Non-Veterans Health Administration Facilities"],"prefix":"10.1093","volume":"187","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8907-3067","authenticated-orcid":false,"given":"Joseph G","family":"Pickard","sequence":"first","affiliation":[{"name":"School of Social Work, University of Missouri\u2013Saint Louis , 63121, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7712-3787","authenticated-orcid":false,"given":"Carissa","family":"van den Berk-Clark","sequence":"additional","affiliation":[{"name":"Department of Family and Community Medicine, Saint Louis University School of Medicine , 63103, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica M","family":"Matthieu","sequence":"additional","affiliation":[{"name":"College for Public Health and Social Justice, Saint Louis University , 63103, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,6,26]]},"reference":[{"volume-title":"2008 Department of Defense Survey of Health Related Behaviors Among Active Duty Military Personnel: A Component of the Defense Lifestyle Assessment Program (DLAP)","year":"2009","author":"Bray","key":"2022102910380680200_R1"},{"issue":"3\u20134","key":"2022102910380680200_R2","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1093\/milmed\/usx014","article-title":"Opioid use patterns among active duty service members and civilians: 2006\u20132014","volume":"183","author":"Kazanis","year":"2018","journal-title":"Mil Med"},{"issue":"4","key":"2022102910380680200_R3","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jsat.2006.09.004","article-title":"Outcomes, performance, and quality\u2014what\u2019s the difference?","volume":"32","author":"McLellan","year":"2007","journal-title":"J Subst Abuse Treat"},{"issue":"3","key":"2022102910380680200_R4","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.evalprogplan.2008.12.003","article-title":"Client and program factors associated with dropout from court mandated drug treatment","volume":"32","author":"Evans","year":"2009","journal-title":"Eval Program Plann"},{"issue":"3","key":"2022102910380680200_R5","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.drugalcdep.2013.03.015","article-title":"How the states stack up: disparities in substance abuse outpatient treatment completion rates for minorities","volume":"132","author":"Arndt","year":"2013","journal-title":"Drug Alcohol Depend"},{"issue":"8","key":"2022102910380680200_R6","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1001\/archpsyc.1975.01760260019001","article-title":"Narcotic use in southeast Asia and afterward. An interview study of 898 Vietnam returnees","volume":"32","author":"Robins","year":"1975","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"2022102910380680200_R7","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s11606-014-3143-z","article-title":"Trends in prevalent and incident opioid receipt: an observational study in Veterans Health Administration 2004\u20132012","volume":"30","author":"Mosher","year":"2015","journal-title":"J Gen Intern Med"},{"issue":"5","key":"2022102910380680200_R8","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/NMD.0b013e31817108ed","article-title":"Posttraumatic stress and its relationship to physical health functioning in a sample of Iraq and Afghanistan War veterans seeking postdeployment VA health care","volume":"196","author":"Jakupcak","year":"2008","journal-title":"J Nerv Ment Dis"},{"issue":"3","key":"2022102910380680200_R9","doi-asserted-by":"crossref","DOI":"10.1097\/SLA.0000000000002372","article-title":"The fifth vital sign postoperative pain predicts 30-day readmissions and subsequent emergency department visits","volume":"266","author":"Hernandez-Boussard","year":"2017","journal-title":"Ann Surg"},{"issue":"11","key":"2022102910380680200_R10","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1016\/j.pain.2014.08.033","article-title":"Patterns of opioid use for chronic noncancer pain in the Veterans Health Administration from 2009 to 2011","volume":"155","author":"Edlund","year":"2014","journal-title":"Pain"},{"issue":"2","key":"2022102910380680200_R11","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJMra1508490","article-title":"Relationship between nonmedical prescription-opioid use and heroin use","volume":"374","author":"Compton","year":"2016","journal-title":"N Engl J Med"},{"key":"2022102910380680200_R12","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.107636","article-title":"Opioid prescribing rates from the emergency department: down but not out","volume":"205","author":"Ali","year":"2019","journal-title":"Drug Alcohol Depend"},{"volume-title":"VA Reduces Prescription Opioid Use by 64% During the Past Eight Years [Press Release]","year":"2020","key":"2022102910380680200_R13"},{"issue":"11","key":"2022102910380680200_R14","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1111\/add.13491","article-title":"Non-medical use of prescription opioids is associated with heroin initiation among US veterans: a prospective cohort study","volume":"111","author":"Banerjee","year":"2016","journal-title":"Addiction"},{"issue":"8","key":"2022102910380680200_R15","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/JGP.0b013e31820d942b","article-title":"Trends in substance abuse treatment 1998\u20132008: increasing older adult first-time admissions for illicit drugs","volume":"19","author":"Arndt","year":"2011","journal-title":"Am J Geriatr Psychiatry"},{"volume-title":"Medication Assisted Treatment","year":"2019","author":"SAMSHA","key":"2022102910380680200_R16"},{"issue":"1","key":"2022102910380680200_R17","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1080\/01634372.2018.1530715","article-title":"Baby boomer\u2019s substance abuse and researcher indifference","volume":"62","author":"Rosen","year":"2019","journal-title":"J Gerontol Soc Work"},{"key":"2022102910380680200_R18","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.drugalcdep.2017.10.007","article-title":"Treatment for opioid use and outcomes in older adults: a systematic literature review","volume":"182","author":"Carew","year":"2018","journal-title":"Drug Alcohol Depend"},{"volume-title":"Statutes, Regulations, and Guidelines","year":"2020","author":"SAMSHA","key":"2022102910380680200_R19"},{"issue":"3","key":"2022102910380680200_R20","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000504363","article-title":"Substance use among older adults: an update on prevalence, etiology, assessment, and intervention","volume":"66","author":"Kuerbis","year":"2020","journal-title":"Gerontology"},{"key":"2022102910380680200_R21","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1007\/s11606-020-06260-9","article-title":"A research agenda for advancing strategies to improve opioid safety: findings from a VHA state of the art conference","volume":"35","author":"Becker","year":"2020","journal-title":"J Gen Intern Med"},{"issue":"2","key":"2022102910380680200_R22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/08897077.2018.1452327","article-title":"Medications for opioid use disorder in the Department of Veterans Affairs (VA) health care system: historical perspective, lessons learned, and next steps","volume":"39","author":"Wyse","year":"2018","journal-title":"Subst Abus"},{"issue":"3","key":"2022102910380680200_R23","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/bmsp.12028","article-title":"Statistical mediation analysis with a multicategorical independent variable","volume":"67","author":"Hayes","year":"2014","journal-title":"Br J Math Stat Psychol"},{"key":"2022102910380680200_R24","volume-title":"State Admissions to Substance Abuse Treatment Services","author":"Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality","year":"2013","edition":"ed."},{"key":"2022102910380680200_R25","volume-title":"Treatment Episode Data Set Discharges (TEDS-D)","author":"SAMSHA","year":"2017","edition":"ed."},{"year":"2003","author":"Leuven","article-title":"PSMATCH2: Stata module to perform full Mahalanobis and propensity score matching, common support graphing, and covariate imbalance testing","key":"2022102910380680200_R26"},{"issue":"3","key":"2022102910380680200_R27","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/ADT.0000000000000063","article-title":"Sex differences in substance abuse treatment adherence in the United States","volume":"14","author":"Bornstein","year":"2015","journal-title":"Addict Disord Their Treat"},{"key":"2022102910380680200_R28","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.drugalcdep.2015.07.004","article-title":"Factors associated with substance use treatment completion in residential facilities","volume":"154","author":"Mutter","year":"2015","journal-title":"Drug Alcohol Depend"},{"volume-title":"Stata Statistical Software: Release 14 [Computer Program]","year":"2015","key":"2022102910380680200_R29"},{"issue":"3","key":"2022102910380680200_R30","doi-asserted-by":"crossref","first-page":"879","DOI":"10.3758\/BRM.40.3.879","article-title":"Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models","volume":"40","author":"Preacher","year":"2008","journal-title":"Behav Res Methods"},{"year":"2018","author":"Kenny","article-title":"Mediation","key":"2022102910380680200_R31"},{"volume-title":"Drug Overdose Deaths in the United States, 1999\u20132018","year":"2020","author":"CDC","key":"2022102910380680200_R32"},{"volume-title":"Opioid Prescribing Is Still High and Varies from County to County","year":"2020","author":"CDC","key":"2022102910380680200_R33"},{"issue":"2","key":"2022102910380680200_R34","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.20843","article-title":"Differences in availability and use of medications for opioid use disorder in residential treatment settings in the United States","volume":"3","author":"Huhn","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"1","key":"2022102910380680200_R35","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2174\/1874473711104010028","article-title":"Buprenorphine and buprenorphine\/naloxone diversion, misuse, and illicit use: an international review","volume":"4","author":"Yokell","year":"2011","journal-title":"Curr Drug Abuse Rev"},{"issue":"5","key":"2022102910380680200_R36","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/ADM.0000000000000045","article-title":"A review of buprenorphine diversion and misuse: the current evidence base and experiences from around the world","volume":"8","author":"Lofwall","year":"2014","journal-title":"J Addict Med"},{"key":"2022102910380680200_R37","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.05.022","article-title":"US physicians\u2019 decision-making during buprenorphine-naloxone treatment: conjoint analyses of dose and office visit adjustments based on patient progress","volume":"204","author":"Knudsen","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"2022102910380680200_R38","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.05.022","article-title":"US physicians\u2019 decision-making during buprenorphine-naloxone treatment: conjoint analyses of dose and office visit adjustments based on patient progress","volume":"204","author":"Knudsen","year":"2019","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"2022102910380680200_R39","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1037\/ser0000333","article-title":"Predicting attrition in long-term residential substance use disorder treatment: a modifiable risk factors perspective","volume":"17","author":"Baker","year":"2020","journal-title":"Psychol Serv"},{"key":"2022102910380680200_R40","doi-asserted-by":"crossref","DOI":"10.1109\/SIEDS.2018.8374721","article-title":"Analyzing national and state opioid abuse treatment completion with multilevel modeling","author":"Pan","year":"2018"},{"issue":"8","key":"2022102910380680200_R41","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1377\/hlthaff.2011.0480","article-title":"The looming expansion and transformation of public substance abuse treatment under the Affordable Care Act","volume":"30","author":"Buck","year":"2011","journal-title":"Health Aff (Millwood)"},{"key":"2022102910380680200_R42","first-page":"23","volume-title":"Caring for the Military: A Guide for Helping Professionals","author":"van den Berk-Clark","year":"2017"}],"container-title":["Military Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/milmed\/article-pdf\/187\/11-12\/1432\/46682638\/usab242.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/milmed\/article-pdf\/187\/11-12\/1432\/46682638\/usab242.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T10:39:31Z","timestamp":1667039971000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/milmed\/article\/187\/11-12\/1432\/6310021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,26]]},"references-count":42,"journal-issue":{"issue":"11-12","published-online":{"date-parts":[[2021,6,26]]},"published-print":{"date-parts":[[2022,10,29]]}},"URL":"https:\/\/doi.org\/10.1093\/milmed\/usab242","relation":{},"ISSN":["0026-4075","1930-613X"],"issn-type":[{"type":"print","value":"0026-4075"},{"type":"electronic","value":"1930-613X"}],"subject":[],"published-other":{"date-parts":[[2022,11,1]]},"published":{"date-parts":[[2021,6,26]]}}}